000			01423nam a2200253 4500
001			ESSALUD
005			20260821150043.0
007			ta
008			t pe ||||| |||| 00| 0 spa d
040			_aBMG
041			_aeng
100			_aLa Vita, Carolyn J. _eAutor _954282
245			_aMucolytics in respiratory failure — A MARCH forward
300			_apáginas: 817-818
520			_aIn patients with acute respiratory failure, difficulty managing respiratory secretions may contribute to adverse outcomes. Airway mucus is a multilayered substance consisting of a viscoelastic glycoprotein gel, a liquid layer, and a thin layer of surfactant. Mucus is cleared from the airway primarily by the action of cilia (mucociliary clearance) and interaction with airflow (cough). In acute respiratory failure, airway irritation from relatively dry inhaled gasses, infection, and inflammation can lead to mucus hypersecretion, and sedation and neuromuscular impairment can contribute to impaired cough.
650			_aMEDICINA CLÍNICA GENERAL _953666
650			_aMEDICINA CLÍNICA HOSPITALARIA _953754
650			_aCUIDADOS INTENSIVOS _95208
650			_aVENTILACIÓN MECÁNICA _937360
650			_aNEUMOLOGÍA _925628
700			_aHardin, C. Corey _954283
773	0		_022717 _922650 _dMassachusetts NEJM Group _oNEJM12 _tThe New England Journal of Medicine _wESSALUD _x0028-4793
942			_cARTICULOS _e2026-08-21 _zsqb
999			_c22858 _d22858